Search details
1.
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.
N Engl J Med
; 385(22): 2036-2046, 2021 11 25.
Article
in English
| MEDLINE | ID: mdl-34818478
2.
Special populations in metastatic renal cell carcinoma.
Curr Opin Oncol
; 36(3): 186-194, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38573208
3.
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma.
Curr Opin Oncol
; 35(3): 206-217, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-37226958
4.
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma.
Curr Opin Oncol
; 34(3): 234-242, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35266906
5.
Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines.
Genes Chromosomes Cancer
; 60(6): 434-446, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33527590
6.
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Cancer
; 127(21): 3957-3966, 2021 Nov 01.
Article
in English
| MEDLINE | ID: mdl-34343338
7.
A challenging frontier - the genomics and therapeutics of nonclear cell renal cell carcinoma.
Curr Opin Oncol
; 33(3): 212-220, 2021 05 01.
Article
in English
| MEDLINE | ID: mdl-33818540
8.
Challenges and opportunities in the management of metastatic renal cell carcinoma: combination therapy and the role of cytoreductive surgery.
Curr Opin Oncol
; 32(3): 240-249, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32195679
9.
Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion.
BMC Cancer
; 19(1): 917, 2019 Sep 13.
Article
in English
| MEDLINE | ID: mdl-31519159
10.
Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma.
Genes Chromosomes Cancer
; 56(6): 484-492, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28196407
11.
Renal cell carcinoma: molecular characterization and evolving treatment paradigms.
Curr Opin Oncol
; 29(3): 201-209, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28252459
12.
Therapeutic Strategies for Hereditary Kidney Cancer.
Curr Oncol Rep
; 18(8): 50, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27325049
13.
Molecular pathways in renal cell carcinoma: recent advances in genetics and molecular biology.
Curr Opin Oncol
; 27(3): 217-23, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25811348
14.
Renal cell carcinoma: molecular biology and targeted therapy.
Curr Opin Oncol
; 26(3): 321-7, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24675233
15.
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.
Clin Cancer Res
; 30(9): 1750-1757, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38393723
16.
Evolving therapeutic targets in renal cell carcinoma.
Curr Opin Oncol
; 25(3): 273-80, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23455028
17.
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis.
EMBO Mol Med
; 15(5): e16877, 2023 05 08.
Article
in English
| MEDLINE | ID: mdl-36987696
18.
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.
J Exp Clin Cancer Res
; 42(1): 99, 2023 Apr 25.
Article
in English
| MEDLINE | ID: mdl-37095531
19.
PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma.
Urology
; 179: 58-70, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37331486
20.
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.
Clin Cancer Res
; 29(2): 341-348, 2023 01 17.
Article
in English
| MEDLINE | ID: mdl-36302175